• Carbapenemase Transmission in CREC: Study Insights

  2026-10-09

  Chen et al. examined 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, integrating carbapenemase-gene localization, antimicrobial susceptibility, transfer potential, mobile-element profiling, and strain typing. The study identifies plasmid-associated blaNDM-1 as a major dissemination concern while showing why its findings support surveillance hypotheses rather than direct estimates of transmission in hospitals or across China.

• LMO2–LDB1 in AML: Evidence and Research Context

  2026-10-09

  A source-grounded overview of how LMO2 and LDB1 may contribute to acute myeloid leukemia, what the 2023 study found across molecular and cellular models, and where plasmid DNA purification fits conceptually without serving as evidence for the mechanism.

• Smoothened Signaling in Honeybee Olfaction

  2026-10-08

  Guo et al. characterize Smoothened (Smo) in Apis mellifera and connect its pharmacological modulation with olfactory receptor expression, electroantennographic responses, and odor-guided behavior. The study supports Smo as a candidate regulator of honeybee olfactory function, while its pharmacological and cross-species limits require careful interpretation.

• Carbapenemase Transmission in CREC: Guangdong Study

  2026-10-08

  Chen et al. integrated gene localization, antimicrobial susceptibility, transfer potential, mobile genetic elements, and strain relatedness to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. The findings identify plasmid-associated blaNDM-1 as a major resistance feature while showing why gene mobility and clonal surveillance should be interpreted together rather than as isolated measurements.

• Nifedipine and the Calcium–Liver Evidence Gap

  2026-10-07

  Nifedipine (BAY-a-1040) is examined here through a mechanistic lens that separates L-type calcium influx inhibition from PXR-driven hepatic adaptation. The article connects cardiac, iron-handling, and microbiological findings while defining what the current evidence does—and does not—support.

• NP-40 Lysis Buffer: Five Evidence Questions

  2026-10-07

  A source-grounded overview of non-denaturing lysis, lysate-based evidence, interpretation of FPR2/ALX research, sample-type scope, and the limitations that separate biochemical observations from therapeutic conclusions.

• Cyclosporin Variants and Mitochondrial Pore Inhibition

  2026-10-06

  Efimov and colleagues combined NMR spectroscopy, molecular dynamics, and a mitochondrial swelling assay to compare cyclosporins B–E with Cyclosporin A. Their results associate greater peptide-backbone flexibility with preserved mitochondrial permeability transition pore inhibition, while the more rigid Cyclosporin E lacked detectable activity in the reported assay range.

• P2Y2 Signaling in Microglial Aβ Clearance

  2026-10-06

  Kim et al. showed that Aβ1–42-treated microglia release extracellular nucleotides that activate P2Y2 receptors, increasing neighboring microglial migration, Aβ uptake, and peptide degradation. The study provides a mechanistic link between cellular stress, purinergic signaling, and microglial Aβ clearance, while remaining limited to primarily mouse-based in vitro evidence.

• Ionizing Radiation and Altered Neuronal Differentiation

  2026-10-05

  Eom et al. showed that ionizing radiation changes neuronal differentiation in C17.2 mouse neural stem-like cells, increasing neurite outgrowth and neuronal markers while producing an atypical neurotransmitter-receptor profile. The study links this phenotype to PI3K-STAT3-mGluR1 and PI3K-p53 signaling and extends the observation to mouse primary neural stem cells, while leaving important questions about in vivo relevance unresolved.

• Irinotecan in Cancer Research: Models and Evidence

  2026-10-05

  This overview examines Irinotecan (CPT-11) as a mechanistically defined topoisomerase I inhibitor in cancer research, with emphasis on model selection, tumor–stroma effects, published assembloid findings, and evidence limitations. It distinguishes supplier-reported cell and xenograft observations from the 2025 peer-reviewed gastric cancer assembloid study and avoids extending those findings beyond their demonstrated context.

• Pentoxifylline and Preterm Monocyte Hyperinflammation

  2026-10-04

  Schüller et al. examined how pentoxifylline modulates LPS-driven monocyte responses across preterm infants, term infants, and adults. The study links reduced inflammatory cytokine production to lower TLR4 expression and signaling, while also revealing age-dependent effects on monocyte phenotype, IL-10 production, and phagocytosis.

• MHY1485 and the mTORC1 Translational Question

  2026-10-03

  A source-grounded perspective on MHY1485 as an mTOR activator and autophagy-modulating research tool, using the LMP2A–mTORC1–GCNT3 axis in nasopharyngeal carcinoma to define opportunities, evidence boundaries, and translational questions.

• SGI-1027: Mechanism-First Epigenetic Assays

  2026-10-02

  SGI-1027 is a DNA methyltransferase inhibitor with a distinctive dual profile: direct DNMT inhibition and DNMT1 degradation. This article explains how to translate that chemistry into assays that distinguish DNA methylation inhibition from lysosomal, apoptotic, and pyroptotic phenotypes.

• Capsaicin-Activated Autophagy in Oxidative-Stressed BMSCs

  2026-10-01

  This study shows that capsaicin preserves rat bone marrow stromal cell function during hydrogen peroxide-induced oxidative stress while supporting antioxidant capacity and osteogenic differentiation. Its proposed mechanism connects TRPV1-associated calcium influx with autophagy and altered PI3K/AKT/mTOR signaling, providing a testable framework for osteoporosis-related cell protection.

• p-Cresyl Sulfate in CKD Cardiovascular Models

  2026-10-01

  p-Cresyl sulfate, also called p-tolyl hydrogen sulfate, is a protein-bound uremic retention solute used to model renal–cardiovascular mechanisms. Evidence links it to endothelial repair impairment and increased valvular interstitial cell calcification through klotho, SIRT1, HIF-1α, NF-κB, and RUNX2 signaling.

7922 records 1/529 page Next 12345 下5页 Last page